Request Deal Involvement

Stanley Capital completed the acquisition of Noden Pharmaceutical Business from PDL BioPharma for $53m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Torreya Capital

financial advisors

Torreya Capital

Leerink Partners

financial advisors

Leerink Partners

Latham & Watkins

legal advisors

Latham & Watkins

Willkie Farr & Gallagher

legal advisors

Willkie Farr & Gallagher

or

Principals

PDL BIOPHARMA INC

vendor

PDL BIOPHARMA INC

NODEN PHARMA DAC

target

NODEN PHARMA DAC

STANLEY CAPITAL PARTNERS

bidder

STANLEY CAPITAL PARTNERS

NODEN PHARMA USA

target

NODEN PHARMA USA

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite